Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features
Abstract
BACKGROUND: Amelanotic malignant melanoma is a subtype of cutaneous melanoma with little or no pigment on visual inspection. It may mimic benign and malignant variants of both melanocytic and nonmelanocytic lesions. OBJECTIVES: To evaluate whether dermoscopy is also a useful technique for the diagnosis of amelanotic/hypomelanotic melanoma (AHM). METHODS: We conducted a retrospective clinical study of 151 amelanotic/hypomelanotic skin lesions from 151 patients with a mean age of 47 years (+/- 17.5 SD). Digitized images of amelanotic/hypomelanotic skin lesions were converted to JPEG format and sent by e-mail from the five participating centres. Lesions included 55 amelanotic/hypomelanotic nonmelanocytic lesions (AHNML), 52 amelanotic/hypomelanotic benign melanocytic lesions (AHBML), and 44 AHM, 10 (23%) of which were nonpigmented, truly amelanotic melanomas (AM). The 44 AHM lesions were divided into thin melanomas (TnM) </= 1 mm (29 cases) and thick melanomas (TkM) > 1 mm (15 cases), according to the Breslow index. Five clinical features (elevation, ulceration, shape, borders and colour) as well as 10 dermoscopic criteria (pigment network, pigmentation, streaks, dots/globules, blue-whitish veil, regression structures, hypopigmentation, leaf-like areas, multiple grey-bluish globules, central white patch) and eight vascular patterns (comma, arborizing, hairpin, dotted, linear irregular, dotted and linear irregular vessels, and milky-red areas) were evaluated in order to achieve clinical and dermoscopic diagnoses. Statistical analyses were performed with the chi2-test and Fisher's exact test, when appropriate. RESULTS: The most frequent and significant clinical features for TnM and TkM were asymmetry and ulceration (the latter only for TkM) compared with AHBML. Irregular dots/globules (62% vs. 35%; P </= 0.03), regression structures (48% vs. 27%; P </= 0.03), irregular pigmentation (41% vs. 11%; P </= 0.03) and blue-whitish veil (10% vs. 0%; P </= 0.03) were the most relevant dermoscopic criteria for TnM in comparison with AHBML. TkM differed significantly from AHBML in frequency of occurrence of irregular pigmentation (87% vs. 11%; P </= 0.03), irregular dots/globules (73% vs. 35%; P </= 0.03), regression structures (67% vs. 27%; P </= 0.03), blue-whitish veil (27% vs. 0%; P </= 0.03) and hypopigmentation (13% vs. 55%; P </= 0.03). Linear irregular vessels and the combination of dotted and linear irregular vessels associated with TnM and TkM were not found in our cases of AHBML and were only rarely seen in AHNML (3.6% and 1.8%, respectively). Moreover, TkM differed significantly from AHBML and TnM in frequency of occurrence of milky-red areas (93% vs. 17%; P </= 0.03 and 93% vs. 31%; P </= 0.01, respectively). The dermoscopic diagnosis of melanoma had a higher sensitivity and specificity than the clinical diagnosis (89% and 96% vs. 65% and 88%, respectively). With the limitation of the small number of cases, vascular patterns were the only dermoscopic criteria for 'truly' AM. In the 10 cases of 'truly' AM, we found milky-red areas in more than half of the cases (six of 10), dotted vessels in four, hairpin vessels in two, linear irregular vessels in two, dotted and linear irregular vessels in two. CONCLUSIONS: Because dermoscopy uses criteria reflecting pigmentation (irregular pigmentation and irregular dots/globules) and vascular patterns, it is a useful technique not only for pigmented melanoma but also for hypomelanotic melanoma. In 'truly' AM, vascular patterns alone may not be sufficient to diagnose melanoma. A combined approach with the clinical information should help in the detection of 'truly' AM.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Study results are not applicable to people with amelanotic melanomas (accounting for 2-8% of all melanomas), or to identify other more common forms of skin cancers such as cutaneous squamous cell carcinoma.
“Study results are also not applicable to people with amelanotic melanomas (accounting for 2-8% of all melanomas),40 or to identify other more common forms of skin cancers such as cutaneous squamous cell carcinoma.”
From Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies (2020) · cites this paper as [40]
Cites
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016 · see citing works
Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet
Argenziano, G., Soyer, H. P., Chimenti, S., Talamini, R., Corona, R., Sera, F., Binder, M., Cerroni, L., Rosa, G. D., Ferrara, G., et al. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.281 · Cited by 1,211 · see citing works
Self-citationPehamberger, H., Steiner, A., & Wolff, K. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70239-4 · Cited by 634 · see citing works
Is Dermoscopy (Epiluminescence Microscopy) Useful for the Diagnosis of Melanoma?
Bafounta, M.-L., Beauchet, A., Aegerter, P., & Saïag, P. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.10.1343 · Cited by 496 · see citing works
Menzies, S. W. (1996) · Archives of Dermatology · doi:10.1001/archderm.1996.03890340038007 · Cited by 424 · see citing works
Amelanotic melanoma: The great masquerader
Koch, S. E., & Lange, J. R. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103981 · Cited by 182 · see citing works
Adachi, E., Maeda, T., Kajiyama, K., Kinukawa, N., Matsumata, T., Sugimachi, K., & Tsuneyoshi, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960515)77:10 · Cited by 140 · see citing works
Melanoma from unknown primary site and amelanotic melanoma.
(1982) · Cited by 111 · see citing works
Sensitivity in the clinical diagnosis of malignant melanoma
Wolf, I. H., Smolle, J., Soyer, H. P., & Kerl, H. (1998) · Melanoma Research · doi:10.1097/00008390-199810000-00007 · Cited by 101 · see citing works
Self-citationAuflichtmikroskopische Charakterisierung von Gefäßmustern in Hauttumoren
Kreusch, J. F., & Koch, F. (1996) · Der Hautarzt · doi:10.1007/s001050050412 · Cited by 85 · see citing works
Menzies, S. W. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.10.1178 · Cited by 85 · see citing works
Adler, M. J., & White, C. R. (1997) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(97)80006-5 · Cited by 71 · see citing works
Amelanotic melanoma presenting as inflammatory plaques
Tschen, J. A., Fordice, D. B., Reddick, M. E., et al. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)80887-0 · Cited by 65 · see citing works
Clinically and dermoscopically featureless melanoma: When prevention fails
Carli, P., Massi, D., GIORGI, V. D., & Giannotti, B. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120569 · Cited by 62 · see citing works
Desmoplastic malignant melanoma: Diagnosis of early clinical lesions
Wharton, J., Carlson, J. A., & Mihm, M. C. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90198-3 · Cited by 54 · see citing works
The dermoscopic versus the clinical diagnosis of melanoma.
Benelli, C., Roscetti, E., Pozzo, V. D., et al. (1999) · PubMed · Cited by 47 · see citing works
Amelanotic melanoma presenting as a pyogenic granuloma.
Elmets, C. A., & Ceilley, R. I. (1980) · PubMed · Cited by 43 · see citing works
Malignant melanoma with clinical and histologic features of Merkel cell carcinoma
House, N. S., Fedok, F. G., Maloney, M. E., et al. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70241-1 · Cited by 41 · see citing works
Desmoplastic malignant melanoma: Rare and difficult to diagnose
Whitaker, D. C., Argényi, Z. B., & Smith, A. C. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70096-x · Cited by 40 · see citing works
Fa, B., Fritsch, P., Kreusch, J. F., et al. (1990) · PubMed · Cited by 36 · see citing works
Macular Amelanotic Melanoma in situ
Pichler, E., & Fritsch, P. O. (2009) · Dermatologica · doi:10.1159/000248586 · Cited by 26 · see citing works
Amelanotic superficial spreading malignant melanoma mimicking Bowen's disease
HOLDER, J. E., Colloby, P., Fletcher, A. A., et al. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.42772.x · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Freeman, K., Dinnes, J., Chuchu, N., Takwoingi, Y., Bayliss, S. E., Matin, R. N., Jain, A., Walter, F. M., Williams, H. C., & Deeks, J. J. (2020) · BMJ · doi:10.1136/bmj.m127 · Cited by 260 · see citing works
Dermoscopy in General Dermatology
Zalaudek, I., Argenziano, G., Di Stefani, A., Ferrara, G., Marghoob, A. A., Hofmann-Wellenhof, R., Soyer, H. P., Braun, R., & Kerl, H. (2006) · Dermatology · doi:10.1159/000089015 · Cited by 252 · see citing works
Self-citationVascularización en dermatoscopia
Martín, J. M., Bella-Navarro, R., & Jordá, E. (2012) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2011.11.005 · Cited by 81 · see citing works
- Authors
- Pizzichetta, M. A., Talamini, R., Stanganelli, I., Puddu, P., Bono, R., Argenziano, G., Veronesi, A., Trevisan, G., Rabinovitz, H., & Soyer, H. P.
- Affiliations
- Centro di Riferimento Oncologico (IT)
- University of Trieste (IT)
- Corresponding author
- Pizzichetta, M.A.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06
- Volume
- 150
- Issue
- 6
- Pages
- 1117-1124
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2042892730
- Cited by
- 236
- References
- 22
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 11 · 2020: 17 · 2019: 9 · 2018: 15 · 2017: 8 · 2016: 11 · 2015: 7 · 2014: 10 · 2013: 12 · 2012: 17
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Dermatology › Cancer and Skin Lesions
- Keywords
- amelanotic melanoma, hypomelanotic melanoma, dermoscopy, benign melanocytic lesions, dermoscopic criteria, vascular patterns, Breslow thickness, differential diagnosis, thin melanoma, thick melanoma
- MeSH terms
- Adult, Aged, Biopsy, Capillaries, Diagnosis, Differential, Female, Humans, Male, Microscopy, Middle Aged, Retrospective Studies, Skin Diseases, Skin Neoplasms, Skin Pigmentation, Chi-Square Distribution, Telemedicine, Melanoma, Amelanotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review